Application | Comment | Organism |
---|---|---|
medicine | utilization for the treatment of cancers | Arabidopsis thaliana |
medicine | utilization for the treatment of cancers | Entamoeba histolytica |
medicine | utilization for the treatment of cancers | Pseudomonas putida |
medicine | utilization for the treatment of cancers | Brevibacterium linens |
medicine | utilization for the treatment of cancers | Fusobacterium nucleatum |
medicine | utilization for the treatment of cancers | Porphyromonas gingivalis |
medicine | utilization for the treatment of cancers | Prevotella denticola |
medicine | utilization for the treatment of cancers | Trichomonas vaginalis |
Crystallization (Comment) | Organism |
---|---|
- |
Arabidopsis thaliana |
- |
Entamoeba histolytica |
- |
Pseudomonas putida |
- |
Brevibacterium linens |
- |
Fusobacterium nucleatum |
- |
Porphyromonas gingivalis |
- |
Prevotella denticola |
- |
Trichomonas vaginalis |
Protein Variants | Comment | Organism |
---|---|---|
C116H | increase of enzyme activity toward cysteine, decrease of enzyme activity toward methionine | Pseudomonas putida |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
myrsinoic acid B | - |
Fusobacterium nucleatum | |
myrsinoic acid B | - |
Porphyromonas gingivalis | |
myrsinoic acid B | - |
Prevotella denticola |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Arabidopsis thaliana | - |
- |
- |
Brevibacterium linens | - |
- |
- |
Entamoeba histolytica | - |
- |
- |
Fusobacterium nucleatum | - |
- |
- |
Porphyromonas gingivalis | - |
- |
- |
Prevotella denticola | - |
- |
- |
Pseudomonas putida | - |
- |
- |
Trichomonas vaginalis | O15564 | - |
- |
Trichomonas vaginalis | O15565 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
seed | - |
Arabidopsis thaliana | - |
Synonyms | Comment | Organism |
---|---|---|
EhMGL1 | - |
Entamoeba histolytica |
EhMGL2 | - |
Entamoeba histolytica |
methionine gamma-lyase | - |
Arabidopsis thaliana |
methionine gamma-lyase | - |
Entamoeba histolytica |
methionine gamma-lyase | - |
Pseudomonas putida |
methionine gamma-lyase | - |
Brevibacterium linens |
methionine gamma-lyase | - |
Fusobacterium nucleatum |
methionine gamma-lyase | - |
Porphyromonas gingivalis |
methionine gamma-lyase | - |
Prevotella denticola |
methionine gamma-lyase | - |
Trichomonas vaginalis |
TvMGL1 | - |
Trichomonas vaginalis |
TvMGL2 | - |
Trichomonas vaginalis |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000389 | - |
- |
Fusobacterium nucleatum | myrsinoic acid B | |
0.0303 | - |
- |
Prevotella denticola | myrsinoic acid B | |
0.0824 | - |
- |
Porphyromonas gingivalis | myrsinoic acid B |
Organism | Comment | Expression |
---|---|---|
Arabidopsis thaliana | higher expression in imbibed seeds | up |
Brevibacterium linens | upregulation under methionine-rich conditions | up |
General Information | Comment | Organism |
---|---|---|
physiological function | involvled in pathogenicity of periodontal bacterium | Porphyromonas gingivalis |
physiological function | isoleucine biosynthesis, sulfur storage, involved in the alternative reverse-transsulfuration pathway, important roe in the resumption process | Arabidopsis thaliana |